{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Effect of Reverse Bevel Nasotracheal Intubation on Epistaxis"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In this randomised controlled trial, 74 patients undergoing right-sided maxillofacial surgery requiring left nasotracheal intubation were enrolled"
      },
      "Participants": {
        "score": 2,
        "evidence": "74 patients undergoing right-sided maxillofacial surgery requiring left nasotracheal intubation were enrolled at Asan Medical Center, Seoul, Korea"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly allocated to the control group (conventional tube direction) or the reverse group (180\u02da reverse bevel direction)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the effect of a 180\u02da reverse bevel and tip direction of the nasotracheal tube on the incidence of epistaxis during left nostril intubation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of epistaxis, assessed via videolaryngoscopy."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using web-based software, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "74 patients undergoing right-sided maxillofacial surgery requiring left nasotracheal intubation were enrolled at Asan Medical Center, Seoul, Korea, between November 2021 and September 2023."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The incidence of epistaxis was significantly lower in the reverse group (9/37 [24.3%]) compared to the control group (20/37 [54.1%], P = 0.009; relative risk: 0.45, 95% CI [0.24, 0.85])."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The incidence of epistaxis was significantly lower in the reverse group (9/37 [24.3%]) compared to the control group (20/37 [54.1%], P = 0.009; relative risk: 0.45, 95% CI [0.24, 0.85])."
      },
      "Harms": {
        "score": 1,
        "evidence": "No nasotracheal tube-related complications were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: KCT0006672."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}